Page 1 of Clinical Trials for ( Medivation AND Inc. ) [SPONSOR-COLLABORATORS], 36 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Determine the Effect of MDV3100 on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of MDV3100 to Identify Potential Predictors of Response or Resistance to Therapy
Last Updated: June 6, 2011
Condition(s): Metastatic Progressive Castration-resistant Prostate Cancer
2
Recruiting
Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer
Last Updated: March 27, 2012
Condition(s): Prostate Cancer
3
Recruiting
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
Last Updated: February 27, 2012
Condition(s): Prostate Cancer
4
Recruiting
Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer
Last Updated: May 11, 2012
Condition(s): Breast Cancer
5
Not yet recruiting
Study of MDV3100 as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer
Last Updated: March 2, 2012
Condition(s): Prostate Cancer
6
Active, not recruiting
Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy
Last Updated: May 9, 2012
Condition(s): Castration-Resistant Prostate Cancer
7
Active, not recruiting
Double-Blind, Placebo-Controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
Last Updated: December 26, 2007
Condition(s): Alzheimer's Disease
8
Active, not recruiting
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
Last Updated: April 14, 2009
Condition(s): Alzheimer's Disease
9
Terminated
An Extension of the CONCERT Protocol (DIM18)
Last Updated: January 18, 2012
Condition(s): Alzheimer's Disease
10
Active, not recruiting
A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer
Last Updated: April 3, 2012
Condition(s): Prostate Cancer; Hormone Refractory Prostate Cancer
11
Active, not recruiting
A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
Last Updated: July 14, 2009
Condition(s): Alzheimer's Disease
12
Completed
A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease
Last Updated: April 13, 2011
Condition(s): Huntington Disease
13
Completed
A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
Last Updated: July 24, 2008
Condition(s): Huntington's Disease
14
Completed
An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease
Last Updated: March 5, 2012
Condition(s): Huntington Disease
15
Completed
Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
Last Updated: January 3, 2008
Condition(s): Huntington's Disease
16
Active, not recruiting
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil
Last Updated: March 11, 2011
Condition(s): Alzheimer's Disease
17
Active, not recruiting
Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease
Last Updated: June 10, 2009
Condition(s): Alzheimer's Disease
18
Terminated
A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease
Last Updated: May 14, 2010
Condition(s): Moderate to Severe Alzheimer
19
Recruiting
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
Last Updated: March 29, 2012
Condition(s): Prostatic Neoplasms
20
Active, not recruiting
A Study to Test if MDV3100 is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy
Last Updated: April 23, 2012
Condition(s): Prostate Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Medivation%2C+Inc.

Page 1 of Clinical Trials for ( Medivation AND Inc. ) [SPONSOR-COLLABORATORS], 36 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About